Skip to main content
Premium Trial:

Request an Annual Quote

Curetis Inks Distribution Deal with ATC for Middle East

NEW YORK (GenomeWeb News) – Molecular diagnostics company Curetis today announced the signing of an exclusive distribution deal with Advanced Technology Company covering the Middle East.

ATC will distribute Curetis' Unyvero solution in the six Gulf Cooperation Council countries and Lebanon. The six GCC countries are Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates.

Placement of the Unyvero instruments will begin in the third quarter. The Kuwait Ministry of Health has approved a clinical evaluation project for Unyvero, and Curetis and ATC will "cooperate" with the project.

"At present, no other region in the world has such a rapidly growing demand for improved diagnostics of infectious diseases. At the same time, there is a need to realign and modernize local health-care systems in the Middle East," Curetis CEO Oliver Schacht said in a statement. "With ATC … we have found a very experienced IVD distributor with a strong presence in this exciting market."

Financial and other terms were not disclosed.

Curetis, founded in 2007, is based in Holzgerlingen, Germany and develops products for diagnosing severe infectious diseases. ATC specializes in total medical systems solutions and healthcare services.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.